EN 12442-3:2000
(Main)Animal tissues and their derivatives utilized in the manufacture of medical devices - Part 3: Validation of the elimination and/or inactivation of viruses and transmissible agents
General Information
- Abstract
This part of prEN 12442 specifies requirements for the validation of elimination and/or inactivation of viruses and/or transmissible agents during the manufacture of medical devices (excluding in-vitro diagnostic medical devices) utilizing materials of animal origin. It is not applicable to bacteria, moulds and yeasts.
- Status
- Withdrawn
- Publication Date
- 19-Sep-2000
- Withdrawal Date
- 14-Dec-2007
- Technical Committee
- CEN/TC 316 - Medical devices utilizing tissues
- Drafting Committee
- CEN/TC 316 - Medical devices utilizing tissues
- Current Stage
- 9960 - Withdrawal effective - Withdrawal
- Start Date
- 15-Dec-2007
- Completion Date
- 15-Dec-2007
- Directive
- Not Harmonized93/42/EEC - Medical devicesOJ Ref: C, C 319 OJ Date: 14-Nov-2001
Relations
- Effective Date
- 22-Dec-2008
Get Certified
Connect with accredited certification bodies for this standard
BSI Group
BSI (British Standards Institution) is the business standards company that helps organizations make excellence a habit.
TÜV Rheinland
TÜV Rheinland is a leading international provider of technical services.
TÜV SÜD
TÜV SÜD is a trusted partner of choice for safety, security and sustainability solutions.
Sponsored listings
Frequently Asked Questions
EN 12442-3:2000 is a standard published by the European Committee for Standardization (CEN). Its full title is "Animal tissues and their derivatives utilized in the manufacture of medical devices - Part 3: Validation of the elimination and/or inactivation of viruses and transmissible agents". This standard covers: This part of prEN 12442 specifies requirements for the validation of elimination and/or inactivation of viruses and/or transmissible agents during the manufacture of medical devices (excluding in-vitro diagnostic medical devices) utilizing materials of animal origin. It is not applicable to bacteria, moulds and yeasts.
This part of prEN 12442 specifies requirements for the validation of elimination and/or inactivation of viruses and/or transmissible agents during the manufacture of medical devices (excluding in-vitro diagnostic medical devices) utilizing materials of animal origin. It is not applicable to bacteria, moulds and yeasts.
EN 12442-3:2000 is classified under the following ICS (International Classification for Standards) categories: 11.120.01 - Pharmaceutics in general. The ICS classification helps identify the subject area and facilitates finding related standards.
EN 12442-3:2000 has the following relationships with other standards: It is inter standard links to EN ISO 22442-3:2007. Understanding these relationships helps ensure you are using the most current and applicable version of the standard.
EN 12442-3:2000 is associated with the following European legislation: EU Directives/Regulations: 93/42/EEC; Standardization Mandates: M/023. When a standard is cited in the Official Journal of the European Union, products manufactured in conformity with it benefit from a presumption of conformity with the essential requirements of the corresponding EU directive or regulation.
EN 12442-3:2000 is available in PDF format for immediate download after purchase. The document can be added to your cart and obtained through the secure checkout process. Digital delivery ensures instant access to the complete standard document.
Standards Content (Sample)
SLOVENSKI STANDARD
01-november-2001
äLYDOVNDWNLYDLQQMLKRYLGHULYDWLXSRUDEOMHQLYSURL]YRGQMLPHGLFLQVNLK
SULSRPRþNRY±GHO 9DOLGDFLMDSULL]ORþLWYLLQDOLLQDNWLYDFLMLYLUXVRYLQQDOH]OMLYLK
DJHQVRY
Animal tissues and their derivatives utilized in the manufacture of medical devices - Part
3: Validation of the elimination and/or inactivation of viruses and transmissible agents
Tierische Gewebe und deren Derivate, die zur Herstellung von Medizinprodukten
eingesetzt werden - Teil 3: Validierung der Ab
...